Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial - Eichhorn, Florian; Klotz, Laura Valentina; Bischoff, Helge; Thomas, Michael; Lasitschka, Felix; Winter, Hauke; Hoffmann, Hans; Eichhorn, Martin E. (BioMed Central, 2019)
In: BMC Cancer, 19 (2019), Nr. 413. pp. 1-8. ISSN 1471-2407